Literature DB >> 1719800

Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis.

M Petein1, P Michel, R van Velthoven, J L Pasteels, M K Brawer, J R Davis, R B Nagle, R Kiss.   

Abstract

Using digital cell image analysis performed on Feulgen-stained nuclei, the nuclear characteristics of prostatic neoplasia, ranging from benign (benign prostatic hyperplasia [BPH]), through dysplastic (prostatic intraepithelial neoplasia [PIN] 1-3), to carcinoma were studied. Four histopathologic groups were studied: group IA (18 samples) contained BPH, PIN 1, and PIN 2 lesions that were from 9 prostate samples free of cancer. Group IB (23 samples) was identical to group IA, contained also BPH, PIN 1, and PIN 2 lesions, but lesions that were from 7 prostate samples where malignant foci were detected elsewhere. Group II (11 samples) were PIN 3 specimens. Group III (24 samples) were carcinomas. Features of neoplastic nuclei were quantified objectively through morphometric (nuclear size), densitometric (nuclear DNA content), and textural (chromatin organization and heterogeneity) parameters. Cell kinetic parameter, i.e., cell proliferation index, was assessed from the densitometric measurement. The proliferation index was significantly higher in PIN 3 and cancers as compared to BPH, PIN 1, and PIN 2 tissues. Morphonuclear characteristics were also dramatically distinct among the four groups. Indeed, the nuclear size and the hyperchromatism of severe prostatic dysplasia were similar to those of carcinomas, these two lesion types showing mean parameter values that were higher as compared to BPH, PIN 1, and PIN 2 lesions. Finally, benign tissues related to mild or moderate dysplasia taken in histologic material in which cancer was present already share the morphonuclear characteristics of severe dysplasia, although they are nonproliferating.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719800     DOI: 10.1093/ajcp/96.5.628

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

Review 1.  Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

Authors:  R Montironi; R Mazzucchelli; J R Marshall; P H Bartels
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

2.  Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.

Authors:  Y Yang; J Hao; X Liu; B Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  Intermediate filament expression in prostate cancer.

Authors:  R B Nagle
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.

Authors:  R Montironi; C M Galluzzi; L Diamanti; I Giannulis; E Pisani; M Scarpelli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  Prostatic intraepithelial neoplasia and prostate-specific antigen.

Authors:  J R Porter; M K Brawer
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

6.  Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.

Authors:  R Montironi; C Magi Galluzzi; M Scarpelli; I Giannulis; L Diamanti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

Review 8.  The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression.

Authors:  A E Cress; I Rabinovitz; W Zhu; R B Nagle
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

9.  Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue.

Authors:  R B Nagle; J Hao; J D Knox; B L Dalkin; V Clark; A E Cress
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

10.  Centrosome loss results in an unstable genome and malignant prostate tumors.

Authors:  Mengdie Wang; Raymond B Nagle; Beatrice S Knudsen; Anne E Cress; Gregory C Rogers
Journal:  Oncogene       Date:  2019-09-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.